<scp>GLP</scp> ‐1 receptor agonists and cardiovascular outcomes in Asian, Black or African American, and White populations: An updated meta‐analysis including the <scp>SOUL</scp> trial
GLP-1RAs reduced MACE risk across populations, with greater relative risk reduction in Asian populations and broadly similar benefits in Black or African American and White populations.
Authors
- Satoshi Yoshiji (ORCID: https://orcid.org/0000-0001-8863-2413)
- Chenyang Su
- Daisuke Yabe
- Hisashi Kamido
- Masashi Hasebe (ORCID: https://orcid.org/0000-0001-7031-2446)
Institutions
- Kyoto University (JP)
- McGill Genome Centre (CA)
- McGill University and Génome Québec Innovation Centre (CA)
- Kitano Hospital (JP)
- Toranomon Hospital (JP)
- McGill University (CA)
Publication Details
- Journal
- Diabetes Obesity and Metabolism
- Published
- 2026-01-21
- DOI
- https://doi.org/10.1111/dom.70458
- Primary Topic
- Diabetes Treatment and Management
- Type
- article
- Field-Weighted Citation Impact
- 0.00
Funders
- TD Bank
- McGill University
- Canada Research Chairs
- Japan Student Services Organization
- Canadian Institutes of Health Research
- Fonds de Recherche du Québec - Santé
- Japan Society for the Promotion of Science